Patents Assigned to TNI Biotech, Inc.
  • Publication number: 20140024588
    Abstract: A method for promoting a sustained increased level of T-cell production in immunocompromised subjects in which method enkephalin peptides are administered according to an intermittent dose schedule. In particular, the method involves treatment of immunocompromised patients which includes the administration of enkephalin, either alone or in conjunction with other therapies, in an initial dosage regimen, with periodic booster dosages of enkephalin as necessary to maintain sustained immune system response.
    Type: Application
    Filed: October 3, 2013
    Publication date: January 23, 2014
    Applicant: TNI BIOTECH, INC.
    Inventor: NICHOLAS P. PLOTNIKOFF
  • Patent number: 8633150
    Abstract: A method for promoting a sustained increased level of T-cell production in immunocompromised subjects in which method enkephalin peptides are administered according to an intermittent dose schedule. In particular, the method involves treatment of immunocompromised patients which includes the administration of enkephalin, either alone or in conjunction with other therapies, in an initial dosage regimen, with periodic booster dosages of enkephalin as necessary to maintain sustained immune system response.
    Type: Grant
    Filed: May 16, 2002
    Date of Patent: January 21, 2014
    Assignee: TNI Biotech, Inc.
    Inventor: Nicholas P. Plotnikoff